Back

Dietary sodium intake and atrial myopathy

8 April 2024 (14:33 - 14:42)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: clinical 1 Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Linda Johnson

Lund University, Malmo (Sweden)

6 More presentations in this session

Presentation thumbnail
Association of the pattern of new-onset post-operative atrial fibrillation with adverse clinical events over 1 year follow-up: insights from the VISION Cardiac Surgery Cohort
Doctor W. McIntyre (Hamilton, CA)
Abstract Slides Video
Presentation thumbnail
Assessing heart rate fragmentation to predict atrial fibrillation in the general population aged 65
Doctor J. Guichard (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Timing of detection of atrial fibrillation recurrence in patients with transient new-onset atrial fibrillation detected during hospitalization for noncardiac surgery or medical illness
Doctor W. McIntyre (Hamilton, CA)
Abstract Slides Video
Presentation thumbnail
Quality of life when switching from a vitamin K antagonist to non-vitamin K antagonist oral anticoagulation in frail older patients with atrial fibrillation
Doctor S. van Doorn (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Clinical significance of new-onset atrial fibrillation in patients with coronary artery or peripheral artery disease: results from the COMPASS trial
Doctor A. Benz (Hamilton, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: clinical 1
Video

The Event

Event poster

EHRA 2024

8 April 2024 14:33 CET
You may be interested in
thumbnail
Congress Session
Basic and Translational Late-Breaking Science 2
29 August 2022
thumbnail
Congress Presentation
Dietary sodium intake and outcomes: a secondary analysis from SODIUM - HF
26 August 2023
thumbnail
Congress Session
Salt and renin angiotensin aldosterone system in hypertension
1 September 2025
thumbnail
Congress Presentation
Markers of atrial myopathy in the UK Biobank: prevalence, consequences, and risk stratification
30 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources